Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease

Immunol Res. 2009;44(1-3):35-41. doi: 10.1007/s12026-008-8068-3.

Abstract

We report on 12 patients with chronic granulomatous disease transplanted with hematopoietic stem cells from matched unrelated (n = 9) or matched sibling donors (n = 3). The most common infectious complication was pulmonary aspergillosis, which nine patients had previously developed. Only 5 of 12 individuals had normal lung function prior to transplantation. At a mean follow-up of 53 months 9 of the 12 patients are alive including 7 of 9 following matched unrelated donor (MUD) transplantation. One patient died from ARDS, another from systemic BK virus infection, the third from complications of chronic graft-versus-host disease. Seven of nine surviving patients have normal lung function now. HSCT from a MUD is an option worth considering when no matched family donor is available. Restricted lung function prior to HSCT does not appear to be a limiting factor for such treatment.

MeSH terms

  • Adolescent
  • Busulfan / administration & dosage
  • Busulfan / therapeutic use
  • Child
  • Child, Preschool
  • Chimerism
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Follow-Up Studies
  • Granulomatous Disease, Chronic / immunology
  • Granulomatous Disease, Chronic / mortality
  • Granulomatous Disease, Chronic / surgery*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Histocompatibility / immunology
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use
  • Postoperative Complications / immunology
  • Postoperative Complications / mortality
  • Pulmonary Aspergillosis / etiology
  • Pulmonary Aspergillosis / mortality
  • Retrospective Studies
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use
  • Young Adult

Substances

  • Cyclophosphamide
  • Vidarabine
  • Busulfan
  • fludarabine
  • Melphalan